Abstract
Patients with major depressive disorder (MDD) often experience inadequate response to antidepressant monotherapy, which contributes to the considerable burden of MDD. Treatment with adjunctive atypical antipsychotics (AA) is a guideline-recommended treatment strategy in patients with inadequate response, yet little is known about healthcare resource utilization (HRU) associated with different AAs. This study evaluated HRU in patients with MDD treated adjunctively with cariprazine versus other AAs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
